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ABSTRACT

Background In January 2019, a new device called the
Amplatzer Piccolo Occluder was approved by the US
Food and Drug Administration for percutaneous closure
of patent ductus arteriosus in infants weighing more than
700 g and of postnatal age more than 3 days. Premature
low-weight infants are predisposed to hypothermia when
transported outside of the thermo-neutral environment.
At our institution, 90% of extremely preterm low-weight
infants developed transient moderate hypothermia in the
cardiac catheterisation suite.
Methods We conducted a study testing multiple
hypotheses aimed at preventing hypothermia in the
cardiac catheterisation suite. Interventions included
increasing ambient room temperature, reducing exposure
to cold environment and reducing overall time spent in the
remote location. The primary outcome was the proportion
of patients who developed transient hypothermia at
the start of the procedure in the cardiac catheterisation
suite. The secondary measures included mean core
body temperature at four different instances, as well as
anaesthesia time, procedure time and radiation exposure.
Results During the study period, 10 patients were
enrolled in each group. The postintervention group saw
a reduction in transient hypothermia from 90% to 40%
(absolute risk reduction 50%, p=0.02). Data analysis
showed an improvement in mean core body temperature
(35.4°C vs 36.4°C, p<0.01) as well as a smaller
percentage drop in temperature (4% vs 1.3%, p<0.01)
between the two groups, both of which were statistically
significant. The anaesthesia time, procedure time and
radiation exposure reduced between the two groups.
Conclusion The application of the interventions
reduced hypothermia in this high-risk population. The
implementation of a protocol with collaboration of a
multidisciplinary team is indispensable in providing
optimal care to extremely preterm infants.

INTRODUCTION
Problem description
Hypothermia in infants is defined by the
WHO as a core body temperature less than
36.5°C.1 Infants are at increased risk of developing hypothermia due to high surface area
to body weight ratio. This risk is further
increased in extremely preterm infants, especially those weighing less than 1600 g, who
lack the body fat and skin integrity for heat

WHAT IS ALREADY KNOWN ON THIS TOPIC
⇒ Preterm infants are at increased risk of developing

hypothermia, which predisposes to pulmonary hypertension, hypoperfusion of vital organs, hypoglycaemia and metabolic acidosis.
⇒ The perioperative period is a risk for developing cold
stress, especially when the procedure is novel for
low-weight infants and performed in and out of the
operating room environment.

WHAT THIS STUDY ADDS
⇒ This single-centre project provides multiple meas-

ures adapted at our hospital to improve thermal care
during these procedures.

HOW THIS STUDY MIGHT AFFECT RESEARCH,
PRACTICE OR POLICY
⇒ Our interventions can be generalised and adapted in

other paediatric and non-paediatric hospitals.

conservation and production. Thus, premature infants are kept in a neutral thermal
environment in the neonatal period which
ensures ideal conditions.2
Transcatheter device closure of patent
ductus arteriosus (PDA) has been accepted
as an innovative and less invasive alternative to surgical ligation for extremely low
birthweight infants. In January 2019, the
Amplatzer Piccolo Occluder (Abbott) was
approved by the US Food and Drug Administration for PDA closure in premature infants.
Since its introduction, extremely low birthweight infants are increasingly undergoing
PDA closure in the cardiac catheterisation
suite under general anaesthesia. A haemodynamically significant PDA causes pulmonary
overcirculation and systemic hypoperfusion.
Furthermore, cold stress predisposes to
pulmonary hypertension, hypoperfusion of
vital organs, hypoglycaemia and metabolic
acidosis.3 4 Therefore, adequate thermal care
is crucial to prevent hypothermia in these
infants.
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Rationale
In August 2019, we collected data retrospectively to quantify hypothermia in low-
weight preterm infants undergoing percutaneous PDA closure in the cardiac catheterisation suite in the past 6 months. We found that 90%
of patients developed transient hypothermia at the start
of the procedure: 20% mild hypothermia (36°C–36.4°C)
and 70% moderate hypothermia (32°C–35.9°C). This
translated to heat loss during patient transport, monitor
placement, induction of anaesthesia, patient positioning
and surgical draping. The contributing factors to hypothermia were identified and addressed by a multidisciplinary team including neonatologists, anaesthesiologists,
interventional cardiologists and cardiac catheterisation
nursing staff members. This work led to the development
of this project to improve thermal care in this vulnerable
patient population.

pulmonary artery, and descending aorta through the
PDA with an aid of 0.035″ Wholey wire. Descending
angiography was performed to measure the size of the
PDA. The Amplatzer Piccolo Occluder was delivered to
the PDA by a specific delivery catheter under fluoroscopy guidance. After a satisfactory position confirmed by
transthoracic echocardiography, the device was released.
Final transthoracic echocardiography was performed. In
this procedure, the role of transthoracic echocardiography is crucial.

Specific aim
We aimed to reduce the proportion of transient hypothermia among low-weight preterm infants undergoing
percutaneous PDA closure by 50% in 6 months.

Intervention
Due to the severity of hypothermia and its deleterious
effect on this population, interventions were implemented as a bundle and not tested individually (figure 1).
The following strategies were adapted in our practice:
► Procedure room temperature: interventional cardiology procedures were seldom done previously on low-
weight infants. Our procedural areas in the cardiac
catheterisation suite were not optimal for this population. On attempting room temperature increase,
a technical problem was identified. The biomedical
engineering department fixed the problem in one of
the rooms, which became the dedicated location for
procedures performed on infants. The catheterisation
suite was heated before patient arrival to the room.
► Staff awareness: discussions were held with the nursing
staff in the catheterisation suite to promote awareness
regarding the dangers of hypothermia. They were
asked to make sure the procedure room and warming
devices such as forced air blanket were preheated
before patient arrival and also that plastic drapes and
warm linen were available in the room.
► Body exposure limitation in the preprocedure time:
efforts were made to keep the patient covered as
much as possible during monitor placement, induction of anaesthesia and positioning. Some infants
had challenging intravenous access or endotracheal
intubation, resulting in an extended time of body
exposure. Therefore, when needed, peripheral intravenous line placement and endotracheal intubation
were performed in the NICU prior to the transport.
► Thermal care during patient transportation: we identified a few patients who became more hypothermic
than others. Detailed review of these cases showed
that some providers usually transport the patient
with an open portable incubator to allow easy patient
accessibility. Education was provided about the importance of maintaining thermo-neutrality in this patient
population. Closed incubator was strongly encouraged for transport.

METHODS
Context
This was a single-centre study conducted at Children’s
Hospital of Michigan. The population consisted of premature infants in the neonatal intensive care unit (NICU)
weighing ≤2.5 kg at the time of the procedure undergoing
transcatheter PDA device closure in the cardiac catheterisation suite.
Preprocedure
On the day of the procedure, patients in the NICU were
transported to the cardiac catheterisation suite accompanied by the procedure room nurse and the anaesthesia
team. The cardiac catheterisation suite and the NICU are
located on the same floor. The transport time is around
5 min. Most patients were mechanically ventilated in the
NICU and a neonatal Ambu bag was used for ventilation
on transport. In most cases, the transport incubator was
open to allow easy and fast patient access in case of an
emergency. On arrival to the cardiac catheterisation suite,
patients were carefully moved to the procedure table and
were kept uncovered during monitor placement. After
induction of anaesthesia, a peripheral intravenous line
was sometimes inserted. The patient was positioned,
prepped and draped in preparation for the procedure. An
underbody Bair Hugger mattress, sometimes preheated,
and plastic covers were used to keep the infants warm.
Core body temperature was measured by an oesophageal
probe, which also served as a landmark on fluoroscopy.
Procedure
Cardiac catheterisation was performed from the femoral
venous access using a 4 Fr Prelude sheath. A 4 Fr Glide
catheter was advanced from the femoral vein to the inferior vena cava, right atrium, right ventricle and main
2

Postprocedure
Patients remained intubated for transport to the NICU.
On NICU arrival, vital signs including axillary temperature measurement were recorded on the anaesthesia
chart.
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Figure 1
►

Core body temperature at procedure start (t1) between April 2019 and February 2020.

Preheated echocardiography gel and gel removal after
ultrasonography: transthoracic echocardiography
was performed multiple times during the procedure.
The echocardiographic gel was preheated simply by
manual friction of the gel package and was immediately wiped after completion of the examination.

Measures
The study period was 14 months (January 2019–February
2020), which were divided into two periods: preintervention (January–August 2019) and postintervention
(September 2019–February 2020). Data on body temperature were collected at four distinct instances: t0 (baseline
temperature at the NICU before transport), t1 (at cardiac
catheterisation suite at the start of the procedure), t2
(at cardiac catheterisation at the end of the procedure)
and t3 (at the NICU after transport). These data were
obtained from the nursing chart in the electronic medical
record (EMR) and the anaesthesia record. Body temperature was measured by an oesophageal temperature probe
in the catheterisation suite and by a digital thermometer
placed in the axilla at the NICU. The primary outcome

was the proportion of hypothermia in the cardiac catheterisation at the start of the procedure (t1).
Subsequent data were also obtained from the EMR,
such as demographic data, anaesthesia and procedure
interval times and radiation exposure. Data were retrospectively collected three times: once for identification
and quantification of the problem and twice after implementation of the measures.
Analysis
Data were expressed as mean±SD or number (%) based
on the type of variables. To compare variables between
the preintervention and postintervention periods, independent sample t-test was used for continuous variables
and Fisher’s exact test was used for categorical variables.
The statistical package used was StatView V.5.0.1 (SAS
Institute). A p value <0.05 was considered statistically
significant.

Table 1 Patients’ characteristics
Group A (n=10)

Group B (n=10)

P value*

Age at procedure (days), mean±SD 24.2±18.1
Weight† (kg), mean±SD (range)
1.1±0.3 (0.72–1.42)

37.9±29.1
1.2±0.5 (0.72–2.5)

0.22
0.48

Gestational age at birth (weeks),
mean±SD
Male:female

25.4±2.8

25.4±2.5

0.99

5:5

7:3

0.65

*P<0.05 is accepted as statistically significant.
†At the time of procedure.
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Table 2 Comparison of mean body temperature (°C)
at four consecutive instances in preintervention and
postintervention patients
Mean temperature (°C)

Group A

Group B

P value

t0
t1

36.9±0.4
35.4±0.9

36.9±0.3
36.4±0.6

0.95
0.007*

t2
t3

36.8±1.5
36.5±1.2

37.0±0.5
36.9±0.4

0.46
0.26

t0: baseline temperature at the NICU before transport; t1: at
cardiac catheterisation suite at the start of the procedure; t2: at
cardiac catheterisation at the end of the procedure; t3: at the NICU
after transport.
*Statistically significant.
NICU, neonatal intensive care unit.

RESULTS
Patient characteristics
The total number of infants was 20. Patients were equally
divided into two groups: preintervention (group A) and
postintervention (group B). The weight range at the
time of the procedure was 0.72–1.42 kg in group A and
0.72–2.5 kg in group B. The weight was 1.5 kg or less in
all patients except one in group B, weighing 2.5 kg. The
mean gestational age was 25.4±2.8 weeks in group A and
25.4±2.5 weeks in group B. All patients except one were
born before 28 weeks of gestation. There was no statistical significance between the two groups in terms of age,
weight, gestational age and gender (table 1).
Body temperature
In group B, transient intraprocedural hypothermia
(<36.5°C) occurred in 40% of patients: 10% mild hypothermia (36°C–36.4°C) and 30% moderate hypothermia
(32°C–35.9°C).
The mean temperature measurements at different
instances are shown in table 2. The mean drop in temperature between t0 and t1 was 4% (±2.2) in group A vs 1.3%
(±1.2) in group B, with a significant p value of 0.004.
Anaesthesia time, procedure time and radiation exposure
The anaesthesia time in group A and group B, as shown in
table 3, was 145.1±19.2 min and 127.3±17.4 min (p=0.04),
respectively. The surgery time in group A and group B
was 102.7±25.3 min and 81.4±20.0 min (p=0.05), respectively. Radiation exposure per body weight was 19.7±7.0

μGym2/kg in group A vs 15.8±8.6 μGym2/kg in group B
(p=0.15).
DISCUSSION
Our study described a multidisciplinary approach to
prevent the development of hypothermia in extremely
preterm low-
weight infants undergoing transcatheter
PDA device closure. With the implementation of multiple
measures, we were able to achieve more than 50% reduction in the development of transient intraoperative hypothermia at the start of the procedure, which was statistically significant. Also, we were able to achieve a statistically significant improvement in mean core body temperature at the beginning of the procedure, thus reflecting
a smaller percentage of temperature drop during patient
transport, monitor placement, induction of anaesthesia,
patient positioning and surgical draping. The results have
proven that our measures to provide better thermal care
were successful.
Small observational studies have shown increased
mortality among preterm patients with hypothermia at
birth.5 Thus, maintaining a normal perioperative core
body temperature is a goal of optimal anaesthetic care.
We implemented multiple interventions to ameliorate
thermal care in our susceptible infants.
A recent retrospective observational study by Hubbard
et al6 on anaesthetic management of catheter-based PDA
closure in neonates weighing <3 kg indicates that the
prevalence of postoperative hypothermia is 3%. Similar
approaches to thermal care were used in our study, such
as transportation in prewarmed transport incubators,
limiting cold exposure by placement of intravenous
catheter and endotracheal tube in the NICU, forced air
warming device, as well as increasing ambient air temperature. Note that hypothermia is defined in the latter study
as a body temperature <36°C. In our study, we defined
hypothermia as a temperature <36.5°C, according to the
WHO definition.1 After our interventions, postoperative
temperature was >36°C in all patients except for only one.
Moreover, we observed a decrease in the anaesthesia
and procedure interval time between the two groups.
Since transcutaneous PDA closure in very low-
weight
infants is a relatively new and technically challenging
treatment, we attribute the shortening in anaesthesia
and procedure time to a steep learning curve among our
interventional cardiologists as well as efforts to reduce the

Table 3 Mean anaesthesia time (min), procedure time (min) and radiation exposure per body weight (μGym2/kg) in the
preintervention and postintervention groups
Anaesthesia time (min)
Procedure time (min)
Radiation exposure (μGym2/kg)

Group A

Group B

P value

145.1±19.2
102.7±25.3
19.7±7.0

127.3±17.4
81.4±20.0
15.8±8.6

0.04*
0.05
0.15

*Statistically significant.
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overall time spent at a remote location. Radiation dosage
was decreased over time, thus reducing the radiation
hazard in this vulnerable population. This was attributed
to technical improvement among the proceduralists.
Although our initiative was successful, our long-term
goal is to completely eliminate perioperative hypothermia
in these susceptible patients. One of the major hurdles
faced was providers’ compliance to changing their
behaviour. Transporting a ventilated infant in a closed
incubator can be of utmost challenge to some providers.
We were able to overcome this difficulty by holding meetings to address people’s concerns, stressing on the importance of maintaining a thermal-
neutral environment
during transport and providing education to increase
familiarity with transport incubators for easy accessibility
in case of an emergency. We believe that regular monitoring of thermal care, appreciation and feedback to the
staff, as well as awareness among newly hired providers
are crucial in maintaining the implemented measures.
The checklist on thermoregulation improvement (online
supplemental file 1) is now accessible to all providers and
added to the anaesthesia protocol for cardiac catheterisation procedures at our institution.
We believe that our project is generalisable to other
hospitals. It is based on team awareness of the dangers of
hypothermia and the simple methods of heat conservation
in infants, including procedure room warming, forced air
warming device, minimal body surface exposure, careful
anaesthesia planning and transport in a neutral thermal
environment. This project demonstrated the importance
of a protocol development in order to achieve adequate
care in this vulnerable patient population.
Our project had some limitations. First, this was a retrospective study. Second, the number of patients included
in the study was limited due to the study’s short total
period (14 months) and the fact that this novel technique is reserved for a failed conservative or pharmacological management of PDA at our institution. Third,
sustainability data beyond February 2020 were beyond
the scope of this study. However, our interventions were
mostly implemented in August and September 2019 and
we observed continued improvement through February
2020. The intervention seems to have translated to
sustained practice changes, but sustainability audit
should also be made. Fourth, due to the small number
of cases and the distant interval separating them, a
plan-do-study-act strategy was not adapted in our study.
In contrast, a bundle of changes were concomitantly
implemented and hence we were unable to determine
the effect of each individual intervention on improved
thermal care. Moreover, a lack of process measures
limits the correlation between the interventions and the
outcomes of the study.
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CONCLUSION
Perioperative hypothermia in extremely preterm infants
is of major concern, most notably for procedures
requiring transport outside of the NICU. The application
of the interventions reduced hypothermia in this high-
risk population. The collaboration of a multidisciplinary
team is indispensable in providing optimal care to premature infants.
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